The Holguin Provincial Oncology Center, located at the Vladimir Ilich Lenin Hospital, is promoting a program focused on the ...
Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) and director of the ...
Study showing that Decipher GRID-derived PORTOS signature predicts benefit from dose-escalated radiation therapy also published in Annals of Oncology SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) ...
Corbus Pharmaceuticals Holdings, Inc. has announced the release of an abstract for its first-in-human dose escalation clinical study of CRB-701 (SYS6002), which targets Nectin-4 in patients with ...
The Lenvima and Welireg combination shows promise in treating metastatic clear cell RCC, with a 47% response rate in phase 2 trials. KIM-1 is emerging as a significant biomarker for prognosis and ...
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium. Following the 2025 Annual ASCO Genitourinary Cancers Symposium, Dr ...
Steven Leonard, BS, Emma Helstrom, BS, Andres Correa, MD, Mohit Sindhani, MS, Nicole Uzzo, BS, Angela Y. Jia, MD, PhD, Alexander Kutikov, MD, Robert Uzzo, MD, MBA ...
Experimental drugs for renal and other genitourinary cancers are more likely to be approved when pharmaceutical companies collaborate on the research, according to a study in JCO Oncology Practice.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that new data presented at the 2025 ASCO Genitourinary Cancers ...
TTUHSC’s Thomas E. Hutson, D.O., Pharm.D., Ph.D., shared groundbreaking findings from the landmark CLEAR study Feb. 13-14 at the 2025 American Society of Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback